Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Baxter
Colorcon
McKinsey
Johnson and Johnson

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Bedford Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for BEDFORD, and what generic and branded alternatives to BEDFORD drugs are available?

BEDFORD has twenty-nine approved drugs.

There are five tentative approvals on BEDFORD drugs.

Summary for Bedford
US Patents:0
Tradenames:22
Ingredients:19
NDAs:29
Patent Litigation for Bedford: See patent lawsuits for Bedford

Drugs and US Patents for Bedford

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bedford CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065465-004 Aug 18, 2008 DISCN No No   Start Trial   Start Trial
Bedford Labs LORAZEPAM PRESERVATIVE FREE lorazepam INJECTABLE;INJECTION 077074-001 Jul 13, 2005 DISCN No No   Start Trial   Start Trial
Bedford Labs PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride INJECTABLE;INJECTION 040524-001 Mar 17, 2004 DISCN No No   Start Trial   Start Trial
Bedford CISPLATIN cisplatin INJECTABLE;INJECTION 074713-001 Nov 14, 2000 DISCN No No   Start Trial   Start Trial
Bedford NEOSAR cyclophosphamide INJECTABLE;INJECTION 087442-005 Mar 30, 1989 DISCN No No   Start Trial   Start Trial
Bedford METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride INJECTABLE;INJECTION 072244-001 Mar 30, 1992 DISCN No No   Start Trial   Start Trial
Bedford Labs METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040709-001 Feb 21, 2007 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Merck
Express Scripts
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.